Systems biology approaches for discovering biomarkers for traumatic brain injury.

The rate of traumatic brain injury (TBI) in service members with wartime injuries has risen rapidly in recent years, and complex, variable links have emerged between TBI and long-term neurological disorders. The multifactorial nature of TBI secondary cellular response has confounded attempts to find cellular biomarkers for its diagnosis and prognosis or for guiding therapy for brain injury. One possibility is to apply emerging systems biology strategies to holistically probe and analyze the complex interweaving molecular pathways and networks that mediate the secondary cellular response through computational models that integrate these diverse data sets. Here, we review available systems biology strategies, databases, and tools. In addition, we describe opportunities for applying this methodology to existing TBI data sets to identify new biomarker candidates and gain insights about the underlying molecular mechanisms of TBI response. As an exemplar, we apply network and pathway analysis to a manually compiled list of 32 protein biomarker candidates from the literature, recover known TBI-related mechanisms, and generate hypothetical new biomarker candidates.

[1]  P. Davies,et al.  c-Abl in Neurodegenerative Disease , 2011, Journal of Molecular Neuroscience.

[2]  T. Ideker,et al.  Supporting Online Material for A Systems Approach to Mapping DNA Damage Response Pathways , 2006 .

[3]  Christopher M. Overall,et al.  Deciphering complex mechanisms in neurodegenerative diseases: the advent of systems biology , 2009, Trends in Neurosciences.

[4]  Richard M. Karp,et al.  DEGAS: De Novo Discovery of Dysregulated Pathways in Human Diseases , 2010, PloS one.

[5]  K. Becker,et al.  The Genetic Association Database , 2004, Nature Genetics.

[6]  J. Ponsford,et al.  Impact of early intervention on outcome after mild traumatic brain injury in children. , 2001, Pediatrics.

[7]  Jaques Reifman,et al.  Categorizing Biases in High-Confidence High-Throughput Protein-Protein Interaction Data Sets* , 2011, Molecular & Cellular Proteomics.

[8]  Van,et al.  A gene-expression signature as a predictor of survival in breast cancer. , 2002, The New England journal of medicine.

[9]  J. Bazarian,et al.  The Economic Impact of S-100B as a Pre-Head CT Screening Test on Emergency Department Management of Adult Patients with Mild Traumatic Brain Injury , 2009 .

[10]  P. Kochanek,et al.  Promising strategies to minimize secondary brain injury after head trauma , 2003, Critical care medicine.

[11]  Li Wang,et al.  CGI: a new approach for prioritizing genes by combining gene expression and protein-protein interaction data , 2007, Bioinform..

[12]  Mathieu Blanchette,et al.  Systematic analysis of the protein interaction network for the human transcription machinery reveals the identity of the 7SK capping enzyme. , 2007, Molecular cell.

[13]  M. DePamphilis,et al.  HUMAN DISEASE , 1957, The Ulster Medical Journal.

[14]  M. Moran,et al.  Large-scale mapping of human protein–protein interactions by mass spectrometry , 2007, Molecular systems biology.

[15]  M. Daly,et al.  PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.

[16]  T. Beems,et al.  GFAP and S100B are biomarkers of traumatic brain injury , 2010, Neurology.

[17]  T. Mathiesen,et al.  Genomic responses in rat cerebral cortex after traumatic brain injury , 2005, BMC Neuroscience.

[18]  Firas H Kobeissy,et al.  Neuroproteomics and systems biology‐based discovery of protein biomarkers for traumatic brain injury and clinical validation , 2008, Proteomics. Clinical applications.

[19]  Trey Ideker,et al.  Hot spots for modulating toxicity identified by genomic phenotyping and localization mapping. , 2004, Molecular cell.

[20]  F. Tortella,et al.  Characterization of a new rat model of penetrating ballistic brain injury. , 2005, Journal of neurotrauma.

[21]  A. Ottens,et al.  High‐capacity peptide‐centric platform to decode the proteomic response to brain injury , 2012, Electrophoresis.

[22]  Jaques Reifman,et al.  Evidence of probabilistic behaviour in protein interaction networks , 2008, BMC Systems Biology.

[23]  T. Leino,et al.  Effects of head and extracranial injuries on serum protein S100B levels in trauma patients. , 2004, The Journal of trauma.

[24]  F. Tortella,et al.  Detection of protein biomarkers using high-throughput immunoblotting following focal ischemic or penetrating ballistic-like brain injuries in rats , 2008, Brain injury.

[25]  Jing Zhao,et al.  Biomarkers for the diagnosis, prognosis, and evaluation of treatment efficacy for traumatic brain injury , 2011, Neurotherapeutics.

[26]  P. Dash,et al.  Biomarkers in the clinical diagnosis and management of traumatic brain injury. , 2008, Molecular diagnosis & therapy.

[27]  Maqc Consortium The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements , 2006, Nature Biotechnology.

[28]  A. Roses,et al.  Identification of plasma biomarkers of TBI outcome using proteomic approaches in an APOE mouse model. , 2012, Journal of neurotrauma.

[29]  B. Snel,et al.  Comparative assessment of large-scale data sets of protein–protein interactions , 2002, Nature.

[30]  Korbinian Strimmer,et al.  BMC Bioinformatics BioMed Central Methodology article A general modular framework for gene set enrichment analysis , 2009 .

[31]  R. Sharan,et al.  Expander: from expression microarrays to networks and functions , 2010, Nature Protocols.

[32]  Jaques Reifman,et al.  Probing the Extent of Randomness in Protein Interaction Networks , 2008, PLoS Comput. Biol..

[33]  C. Borlongan,et al.  Genetic and histologic evidence implicates role of inflammation in traumatic brain injury-induced apoptosis in the rat cerebral cortex following moderate fluid percussion injury , 2010, Neuroscience.

[34]  E. Diamandis,et al.  Strategies for discovering novel cancer biomarkers through utilization of emerging technologies , 2008, Nature Clinical Practice Oncology.

[35]  Tobias Müller,et al.  Identifying functional modules in protein–protein interaction networks: an integrated exact approach , 2008, ISMB.

[36]  T. Werner Bioinformatics applications for pathway analysis of microarray data. , 2008, Current opinion in biotechnology.

[37]  Jason A. Papin,et al.  Metabolic pathways in the post-genome era. , 2003, Trends in biochemical sciences.

[38]  Sebastian Bernhardsson,et al.  The Blind Watchmaker Network: Scale-Freeness and Evolution , 2008, PloS one.

[39]  Alexander R. Pico,et al.  WikiPathways: Pathway Editing for the People , 2008, PLoS biology.

[40]  R. Aebersold,et al.  Mass spectrometry-based proteomics , 2003, Nature.

[41]  Carl W. Cotman,et al.  Axonal mRNA in Uninjured and Regenerating Cortical Mammalian Axons , 2009, The Journal of Neuroscience.

[42]  A. Gabrielli,et al.  Clinical Utility of Serum Levels of Ubiquitin C-terminal Hydrolase as a Biomarker for Severe Traumatic Brain Injury , 2022 .

[43]  C. Landry,et al.  An in Vivo Map of the Yeast Protein Interactome , 2008, Science.

[44]  R. Sharan,et al.  Protein networks in disease. , 2008, Genome research.

[45]  P. Dash,et al.  Human traumatic brain injury alters plasma microRNA levels. , 2010, Journal of neurotrauma.

[46]  Michael L. Creech,et al.  Integration of biological networks and gene expression data using Cytoscape , 2007, Nature Protocols.

[47]  B. Golomb,et al.  Prevalence and Psychological Correlates of Traumatic Brain Injury in Operation Iraqi Freedom , 2010, The Journal of head trauma rehabilitation.

[48]  H. Lehrach,et al.  A Human Protein-Protein Interaction Network: A Resource for Annotating the Proteome , 2005, Cell.

[49]  T. Speed,et al.  Neuron-Specific mRNA Complexity Responses during Hippocampal Apoptosis after Traumatic Brain Injury , 2004, The Journal of Neuroscience.

[50]  J. Carazo,et al.  GENECODIS: a web-based tool for finding significant concurrent annotations in gene lists , 2007, Genome Biology.

[51]  F. Tortella,et al.  Novel Differential Neuroproteomics Analysis of Traumatic Brain Injury in Rats* , 2006, Molecular & Cellular Proteomics.

[52]  Benno Schwikowski,et al.  Discovering regulatory and signalling circuits in molecular interaction networks , 2002, ISMB.

[53]  N. Friedman,et al.  Metabolic labeling of RNA uncovers principles of RNA production and degradation dynamics in mammalian cells , 2011, Nature Biotechnology.

[54]  F. Tortella,et al.  P43/pro-EMAPII: a potential biomarker for discriminating traumatic versus ischemic brain injury. , 2009, Journal of Neurotrauma.

[55]  John Q. Trojanowski,et al.  Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury , 2004, Experimental Neurology.

[56]  Jaques Reifman,et al.  PathNet: a tool for pathway analysis using topological information , 2012, Source Code for Biology and Medicine.

[57]  T. Ideker,et al.  A new approach to decoding life: systems biology. , 2001, Annual review of genomics and human genetics.

[58]  F. Tortella,et al.  Elevated levels of serum glial fibrillary acidic protein breakdown products in mild and moderate traumatic brain injury are associated with intracranial lesions and neurosurgical intervention. , 2012, Annals of emergency medicine.

[59]  Ziv Bar-Joseph,et al.  Biological interaction networks are conserved at the module level , 2011, BMC Systems Biology.

[60]  R. Bullock,et al.  Glial neuronal ratio: a novel index for differentiating injury type in patients with severe traumatic brain injury. , 2012, Journal of neurotrauma.

[61]  T. Ideker,et al.  Network-based classification of breast cancer metastasis , 2007, Molecular systems biology.

[62]  B. Jordan,et al.  Chronic Traumatic Brain Injury Associated with Boxing , 2000, Seminars in neurology.

[63]  Yoshihiro Yamanishi,et al.  KEGG for linking genomes to life and the environment , 2007, Nucleic Acids Res..

[64]  A. Barabasi,et al.  The human disease network , 2007, Proceedings of the National Academy of Sciences.

[65]  J. Foekens,et al.  Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer , 2005, The Lancet.

[66]  T. Liu,et al.  Toward an understanding of the protein interaction network of the human liver , 2011, Molecular systems biology.

[67]  Joshua M. Stuart,et al.  A Gene-Coexpression Network for Global Discovery of Conserved Genetic Modules , 2003, Science.

[68]  P. Kochanek,et al.  Conventional and functional proteomics using large format two-dimensional gel electrophoresis 24 hours after controlled cortical impact in postnatal day 17 rats. , 2002, Journal of neurotrauma.

[69]  S. Kasif,et al.  Network-Based Analysis of Affected Biological Processes in Type 2 Diabetes Models , 2007, PLoS genetics.

[70]  Alex Matter,et al.  Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug , 2002, Nature Reviews Drug Discovery.

[71]  J. Ioannidis,et al.  Comparison of effect sizes associated with biomarkers reported in highly cited individual articles and in subsequent meta-analyses. , 2011, JAMA.

[72]  James R. Knight,et al.  A comprehensive analysis of protein–protein interactions in Saccharomyces cerevisiae , 2000, Nature.

[73]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[74]  J. Hutchison,et al.  Biomarkers and diagnosis; protein biomarkers in serum of pediatric patients with severe traumatic brain injury identified by ICAT-LC-MS/MS. , 2007, Journal of neurotrauma.

[75]  T. Beems,et al.  Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury , 2004, Neurology.

[76]  D. Hovda,et al.  Molecular and Physiological Responses to Juvenile Traumatic Brain Injury: Focus on Growth and Metabolism , 2010, Developmental Neuroscience.

[77]  A. Barabasi,et al.  High-Quality Binary Protein Interaction Map of the Yeast Interactome Network , 2008, Science.

[78]  R. Ozawa,et al.  A comprehensive two-hybrid analysis to explore the yeast protein interactome , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[79]  J. Powell,et al.  Accuracy of mild traumatic brain injury diagnosis. , 2008, Archives of physical medicine and rehabilitation.

[80]  H. Thompson,et al.  Experimental models of traumatic brain injury: Do we really need to build a better mousetrap? , 2005, Neuroscience.

[81]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[82]  J. Hutchison,et al.  Protein Biomarkers in Serum of Pediatric Patients with Severe Traumatic Brain Injury Identified by ICAT–LC-MS/MS , 2007 .

[83]  J. Brisman,et al.  Reliability of S100B in predicting severity of central nervous system injury , 2007, Neurocritical care.

[84]  Joshua M. Stuart,et al.  Conserved Genetic Modules 5 / 29 / 2003 1 A gene co-expression network for global discovery of conserved genetic modules in H . sapiens , D . melanogaster , C . elegans , and S . cerevisiae , 2003 .

[85]  Jackson Streeter,et al.  Blood-based diagnostics of traumatic brain injuries , 2011, Expert review of molecular diagnostics.

[86]  Jaques Reifman,et al.  A Novel Scoring Approach for Protein Co-Purification Data Reveals High Interaction Specificity , 2009, PLoS Comput. Biol..

[87]  A. Barabasi,et al.  Drug—target network , 2007, Nature Biotechnology.

[88]  Francisco Tirado,et al.  GeneCodis: interpreting gene lists through enrichment analysis and integration of diverse biological information , 2009, Nucleic Acids Res..

[89]  S. Marshall,et al.  Association between Recurrent Concussion and Late-Life Cognitive Impairment in Retired Professional Football Players , 2005, Neurosurgery.

[90]  Trey Ideker,et al.  Building with a scaffold: emerging strategies for high- to low-level cellular modeling. , 2003, Trends in biotechnology.

[91]  Ioannis Xenarios,et al.  Network-Guided Analysis of Genes with Altered Somatic Copy Number and Gene Expression Reveals Pathways Commonly Perturbed in Metastatic Melanoma , 2011, PloS one.

[92]  B. Romner,et al.  Can Low Serum Levels of S100B Predict Normal CT Findings After Minor Head Injury in Adults?: An Evidence‐Based Review and Meta‐Analysis , 2010, The Journal of head trauma rehabilitation.

[93]  C. Kavalci,et al.  The value of serum tau protein for the diagnosis of intracranial injury in minor head trauma. , 2007, The American journal of emergency medicine.

[94]  P. Dash,et al.  High‐density microarray analysis of hippocampal gene expression following experimental brain injury , 2002, Journal of neuroscience research.

[95]  D. Kell,et al.  Here is the evidence, now what is the hypothesis? The complementary roles of inductive and hypothesis-driven science in the post-genomic era. , 2004, BioEssays : news and reviews in molecular, cellular and developmental biology.

[96]  J. Ponsford,et al.  Impact of early intervention on outcome following mild head injury in adults , 2002, Journal of neurology, neurosurgery, and psychiatry.

[97]  B. Stoica,et al.  Gene expression profile changes are commonly modulated across models and species after traumatic brain injury. , 2003, Journal of neurotrauma.

[98]  E. Jauch,et al.  C-tau biomarker of neuronal damage in severe brain injured patients: association with elevated intracranial pressure and clinical outcome , 2002, Brain Research.

[99]  Pooja Mittal,et al.  A novel signaling pathway impact analysis , 2009, Bioinform..

[100]  Lincoln Stein,et al.  Reactome: a database of reactions, pathways and biological processes , 2010, Nucleic Acids Res..

[101]  B. Palsson,et al.  The model organism as a system: integrating 'omics' data sets , 2006, Nature Reviews Molecular Cell Biology.

[102]  T. Ideker,et al.  Modeling cellular machinery through biological network comparison , 2006, Nature Biotechnology.

[103]  Pei Wang,et al.  Gene expression profiling of peripheral blood leukocytes identifies and validates ABCB1 as a novel biomarker for Alzheimer's disease , 2011, Neurobiology of Disease.

[104]  E. Braunwald,et al.  Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. , 2001, JAMA.

[105]  F. Tortella,et al.  Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study , 2011, Critical care.

[106]  T. Kaneko,et al.  Serum glial fibrillary acidic protein is a highly specific biomarker for traumatic brain injury in humans compared with S-100B and neuron-specific enolase. , 2010, The Journal of trauma.

[107]  A. Gabrielli,et al.  Biokinetic analysis of ubiquitin C-terminal hydrolase-L1 (UCH-L1) in severe traumatic brain injury patient biofluids. , 2011, Journal of neurotrauma.

[108]  A. Barabasi,et al.  An empirical framework for binary interactome mapping , 2008, Nature Methods.

[109]  R. Anderson,et al.  High serum S100B levels for trauma patients without head injuries. , 2001, Neurosurgery.

[110]  H. Weng,et al.  Tau proteins in serum predict outcome after severe traumatic brain injury. , 2010, The Journal of surgical research.

[111]  S. L. Wong,et al.  Towards a proteome-scale map of the human protein–protein interaction network , 2005, Nature.

[112]  Jaques Reifman,et al.  Inferring high-confidence human protein-protein interactions , 2012, BMC Bioinformatics.

[113]  V. Mathura,et al.  Genomic analysis of response to traumatic brain injury in a mouse model of Alzheimer's disease (APPsw) , 2007, Brain Research.

[114]  Hanlee P. Ji,et al.  The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. , 2006, Nature biotechnology.

[115]  R. Aebersold,et al.  Applying mass spectrometry-based proteomics to genetics, genomics and network biology , 2009, Nature Reviews Genetics.

[116]  S. DeKosky,et al.  Traumatic brain injury: football, warfare, and long-term effects. , 2010, Minnesota medicine.

[117]  Antonio Belli,et al.  Transcriptomics of traumatic brain injury: gene expression and molecular pathways of different grades of insult in a rat organotypic hippocampal culture model. , 2010, Journal of neurotrauma.

[118]  A. Faden,et al.  Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies. , 2010, Trends in pharmacological sciences.

[119]  G. Pasinetti,et al.  From proteomics to biomarker discovery in Alzheimer's disease , 2005, Brain Research Reviews.

[120]  Doheon Lee,et al.  Inferring Pathway Activity toward Precise Disease Classification , 2008, PLoS Comput. Biol..

[121]  A. Gabrielli,et al.  Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury* , 2010, Critical care medicine.

[122]  Ron Shamir,et al.  Identification of functional modules using network topology and high-throughput data , 2007, BMC Systems Biology.

[123]  C. Werner,et al.  Pathophysiology of traumatic brain injury. , 2007, British journal of anaesthesia.

[124]  Arun K. Ramani,et al.  Protein interaction networks from yeast to human. , 2004, Current opinion in structural biology.

[125]  Rainer Breitling,et al.  Graph-based iterative Group Analysis enhances microarray interpretation , 2004, BMC Bioinformatics.

[126]  A. Barabasi,et al.  Network biology: understanding the cell's functional organization , 2004, Nature Reviews Genetics.

[127]  Bart De Moor,et al.  BioMart and Bioconductor: a powerful link between biological databases and microarray data analysis , 2005, Bioinform..

[128]  A. Gabrielli,et al.  αII-spectrin breakdown products (SBDPs): diagnosis and outcome in severe traumatic brain injury patients. , 2010, Journal of neurotrauma.

[129]  Peter Uetz,et al.  Benchmarking yeast two‐hybrid systems using the interactions of bacterial motility proteins , 2009, Proteomics.